Crossmark

Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2

Published Online: 2015-04-07

Published Print: 2015-06-01

Authors

Wu, Florence TH

Lee, Christina R

Bogdanovic, Elena

Prodeus, Aaron

Gariépy, Jean

Kerbel, Robert S
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research (CIHR MOP 119499)

Canadian Breast Cancer Foundation

Cancer Research Society/CURE FOUNDATION (CRS 1011391)

Vanier Canada Graduate Scholarship

CIHR

McLaughlin Centre
License Information

Text and Data Mining valid from 2015-04-07

Version of Record valid from 2015-04-07
More Information

Article History

Received: 29 April 2014

Revised: 3 March 2015

Accepted: 9 March 2015

First Online: 7 April 2015

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current